Sickle Cell Clinical Trial Aims to Cure Disease by Correcting Patient's Mutated Gene
Sickle cell disease is a genetic blood disorder that affects the structure and function of hemoglobin, reduces the ability of red blood cells to transport oxygen efficiently, and progresses to a chronic vascular disease that affects approximately 100,000 Americans and millions worldwide, with a disproportionate effect on the Black community. | Benioff Children’s Oakland Receives $17M in Grants to Launch 4-Year Study Using CRISPR to Eradicate Sickle Cell Mutation By Lorna Fernandes UCSF Benioff Children’s Hospital Oakland has received the largest research trial grant in its history to launc...
Source: postnewsgroup.com